Please assess the completion status of the following clinical trial:

Trial Title: Validating a New Severity Score System for Adults With Type 1 Gaucher Disease (GD1)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: None
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients with Type 1 Gaucher disease regardless of treatment status who are enrolled in the International Collaborative Gaucher Group (ICCG) Gaucher Registry and who are cared for at one of the participating research sites.~Exclusion Criteria:~* Children under the age of 18 years~  * Patients with Type 3 Gaucher disease~ * Patients who have declined to be enrolled in the ICCG Gaucher Registry~ * Patients not cared for at one of the participating research sites

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Adults with Type 1 Gaucher disease (GD1) (Type: None): Adults with GD1 who are cared for at one of the participating research sites whether treatment naive or treated in past or currently with imiglucerase enzyme replacement treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).